Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 219,500 | 41,600 | 74,300 | 69,700 | 305,100 |
| Depreciation Amortization | 169,600 | 97,700 | 63,900 | 29,700 | 118,000 |
| Income taxes - deferred | 46,000 | 600 | -3,200 | -1,700 | -2,400 |
| Accounts receivable | -16,200 | -114,700 | -34,700 | 42,100 | 49,000 |
| Accounts payable and accrued liabilities | -1,600 | 3,500 | 8,000 | 20,100 | 18,700 |
| Other Working Capital | -145,000 | -273,900 | -185,600 | -107,700 | 8,800 |
| Other Operating Activity | 47,900 | 237,300 | 52,700 | -47,100 | 38,800 |
| Operating Cash Flow | $320,200 | $-7,900 | $-24,600 | $5,100 | $536,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -224,100 | -178,300 | -123,100 | -56,100 | -141,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -10,000 |
| Investing Cash Flow | $-224,100 | $-178,300 | $-123,100 | $-56,100 | $-151,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -25,300 | -16,900 | -11,300 | -16,200 | 435,900 |
| Debt Repayment | -10,600 | -10,600 | -10,600 | N/A | -373,000 |
| Common Stock Issued | N/A | N/A | N/A | 6,900 | N/A |
| Common Stock Repurchased | -106,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 900 | -3,500 | -4,100 | -12,900 | 6,600 |
| Financing Cash Flow | $-141,000 | $-31,000 | $-26,000 | $-22,200 | $69,500 |
| Exchange Rate Effect | -300 | -300 | -100 | -300 | -1,000 |
| Beginning Cash Position | 621,500 | 621,500 | 621,500 | 621,500 | 168,000 |
| End Cash Position | 576,300 | 404,000 | 447,700 | 548,000 | 621,500 |
| Net Cash Flow | $-45,200 | $-217,500 | $-173,800 | $-73,500 | $453,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 320,200 | -7,900 | -24,600 | 5,100 | 536,000 |
| Capital Expenditure | -224,100 | -178,300 | -123,100 | -56,100 | -141,000 |
| Free Cash Flow | 96,100 | -186,200 | -147,700 | -51,000 | 395,000 |